UNH Raised to $475
BofA raises UnitedHealth price target to $475 from $450, keeps Buy rating
UNH BofA raised the firm's price target on UnitedHealth to $475 from $450 and keeps a Buy rating on the shares.
As the firm gets more comfortable with cost trend going into Q2 earnings, it cites a higher multiple and "the continuous positive outlook on trend" and the better visibility into the rest of the year for its raised target